Literature DB >> 1792318

Breast irradiation in the lateral decubitus position: technique of the Institut Curie.

A Fourquet1, F Campana, J C Rosenwald, J R Vilcoq.   

Abstract

Breast irradiation in the lateral decubitus (LD) position is a technique used at the Institut Curie for more than 30 years in the breast-conserving management of patient with breast cancer. This technique is described in detail in this article. The patient's position allows the breast to flatten over a support, hence providing a rather homogeneous thickness throughout the treated volume. Dose at mid-thickness on the beam axis can be easily determined from entrance and exit dose measurements. Disadvantages and advantages of the LD technique are discussed. We presently recommend this technique for patients with large breasts (more than 6 cm thickness in LD position).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1792318     DOI: 10.1016/0167-8140(91)90160-i

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  6 in total

1.  Quality assurance of the EORTC Trial 22881/10882: boost versus no boost in breast conserving therapy. An overview.

Authors:  G van Tienhoven; B J Mijnheer; H Bartelink; D G González
Journal:  Strahlenther Onkol       Date:  1997-04       Impact factor: 3.621

2.  The role of a prone setup in breast radiation therapy.

Authors:  Nelly Huppert; Gabor Jozsef; Keith Dewyngaert; Silvia Chiara Formenti
Journal:  Front Oncol       Date:  2011-10-11       Impact factor: 6.244

Review 3.  Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review.

Authors:  Sofiane Allali; Youlia Kirova
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

Review 4.  Cardiotoxicity of Radiation Therapy: Mechanisms, Management, and Mitigation.

Authors:  P Ell; J M Martin; D A Cehic; D T M Ngo; A L Sverdlov
Journal:  Curr Treat Options Oncol       Date:  2021-06-10

Review 5.  Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients?

Authors:  S Allali; A Beddok; Y Kirova
Journal:  Cancer Radiother       Date:  2021-07-01       Impact factor: 1.217

6.  Second malignancies after breast cancer: the impact of different treatment modalities.

Authors:  Y M Kirova; Y De Rycke; L Gambotti; J-Y Pierga; B Asselain; A Fourquet
Journal:  Br J Cancer       Date:  2008-02-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.